Defy Medical Appears in 31.1% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.

Mark HuntleyBy Mark HuntleyFounder and CEO
10 minutes read

Key Takeaways

  • Defy Medical appears in 113 of 363 benchmark answers and is recommended in 81, but it rarely takes the top spot.
  • The main issues to verify are pricing descriptions and whether a membership is required, with one high-priority conflict identified.
  • The company’s TRT service page is the most cited site page and should anchor consistency updates.
  • Buyer questions cluster around “best TRT clinic” comparisons, making comparison-focused content a clear priority.

Answer Capsule

In November 2026, Defy Medical appeared in 113 of 363 AI answers included in the TRT Clinics benchmark (31.13%). It received 81 recommendations (22.31%), with 64 Top 3 placements and 12 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.

Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. This edition establishes a research baseline. It does not claim a change from earlier editions measured on a different basis. Conflicting AI claims require verification before corrections are proposed.

Current AI visibility

Questions This Section Answers

  • How do Defy Medical mentions, recommendations and placements compare with its TRT Clinics peers?

Defy Medical recorded 113 mentions (31.13%) and 81 recommendations (22.31%) across 363 answers included in the benchmark. Top 3 placements numbered 64; first-place recommendations numbered 12. Framing among its mentions was 82 positive, 31 neutral and 0 negative.

Rank

Company

Mentions

Mention rate

Recommendations

Recommendation rate

Top 3

Top 3 rate

#1

#1 rate

1

Hone Health

271

74.66%

146

40.22%

123

33.88%

64

17.63%

2

Defy Medical

113

31.13%

81

22.31%

64

17.63%

12

3.31%

3

Maximus

116

31.96%

64

17.63%

49

13.50%

18

4.96%

4

Marek Health

78

21.49%

39

10.74%

30

8.26%

7

1.93%

5

Henry Meds

86

23.69%

35

9.64%

28

7.71%

6

1.65%

6

Fountain TRT

57

15.70%

25

6.89%

13

3.58%

1

0.28%

7

Renew Vitality

6

1.65%

5

1.38%

5

1.38%

0

0.00%

8

Low T Center

11

3.03%

4

1.10%

2

0.55%

1

0.28%

9

BioTE

7

1.93%

0

0.00%

0

0.00%

0

0.00%

9

Craft Concierge

0

0.00%

0

0.00%

0

0.00%

0

0.00%

Defy Medical sits in the leading group of this benchmark, with a substantial share of answers mentioning it and a large portion of those mentions also carrying a recommendation. That combination matters more than raw reach: the company is not only appearing but often being endorsed in the same answer.

Placement is where the picture narrows. The company appears in many shortlists but rarely takes the top spot, so its visibility is broad rather than dominant. The practical implication is that the brand is already in the consideration set; the work is about strengthening how it is described and where it lands.

We would treat this as a starting position, not a score to defend. A visibility comparison against the leaders, paired with a short list of claims worth checking, gives the client a clear sense of which gaps are about presence and which are about accuracy.

What changed since last month

Questions This Section Answers

  • How did Defy Medical counts and coverage differ across the available monthly snapshots?

Metric

Nov 2026

Mentions

113 / 363 (31.13%)

Recommendations

81 / 363 (22.31%)

Top 3 recommendations

64 / 363 (17.63%)

#1 recommendations

12 / 363 (3.31%)

Only months with verified results are shown. Monthly sample coverage is listed in Methodology.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

This edition is the first broad baseline, so the figures describe where Defy Medical stands now rather than a movement from earlier months. Earlier editions asked a narrower set of questions, which makes direct comparison misleading; the archive remains useful as context, not as a trend line.

That distinction shapes how the client should read the numbers. A single month of results cannot show whether visibility is improving or slipping, and the wider question set changes what an answer total means. The honest reading is a snapshot with a known comparability limit.

Our recommendation is to hold this baseline steady and compare future editions only once they use the same screening scope. Until then, the useful work is verification and content quality, not chasing month-to-month movement that the evidence cannot support.

AI recommendation trend

Observed recommendation rate (%), Nov 2026

  • Defy Medicalno change
    Nov 202622.31%

Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.

/ Take the next step

Want to Understand Your AI Citation Footprint?

We start every engagement with a full audit of how AI systems reference your brand today.

Measurable, Repeatable Programme

Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge

Citation Architecture Review

Identify which high-authority community sources are and aren't working in your favour across AI platforms.

AI Visibility Audit

Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.

Step 1. Measure

Questions This Section Answers

  • What should the agency measure and verify first for Defy Medical?

AI answers contained 3 conflicting claims about Defy Medical: 0 critical, 1 high, 2 medium, 0 low. Of these, 1 was rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

The research surfaced a small set of conflicting claims about Defy Medical, and only one of them was rated high priority. That ranking is a triage tool, not a verdict: it tells the client where a fact check is most worth doing first, not that any company or publisher got something wrong.

A visibility comparison adds the other half of the picture. Knowing which competitors appear more often and which appear alongside endorsements helps the client decide whether to invest in reach, in accuracy, or in both. The two views answer different questions and should be read together.

We would propose a baseline scorecard that pairs the competitive position with a scoped list of claims to verify. Each claim gets an owner and an evidence requirement, so the client can act on the high-priority item without treating the rest as settled.

Step 2. Make the website consistent

Questions This Section Answers

  • Which recorded claim differences about Defy Medical should be verified before proposed page edits?

Review topic

Severity

Recorded AI claim A

Recorded AI claim B

monthly price

medium

$200+/mo

~$175/mo first year, ~$125/mo after

monthly price

medium

$200+/mo

~$175/mo first year, ~$125/mo after

membership requirement

high

membership required

no mandatory membership; bills per consultation/treatment

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

The disputed topics are narrow and concrete: how the monthly price is described and whether a membership is required. Both columns in the review are quotes from AI answers, not verified company facts, so the first task is to establish the entity, the date and the source behind each version before anyone decides a correction is warranted.

Different dates can explain an apparent conflict, particularly on pricing. A figure that was accurate at one point may simply be older than another. That possibility has to be ruled out before the client treats either version as wrong.

We would propose a fact-review register covering these topics, with current primary-source verification required before any page brief is written. Where the facts are confirmed, a brief can guide a conditional update; where they are not, the item stays open rather than becoming a correction request.

Step 3. Align the external narrative

Questions This Section Answers

  • Which cited third-party pages are relevant to fact review for Defy Medical?

Cited page selected for review

Citation appearances in all captured answers

Answers mentioning the company

Conflicting claims linked to this page

https://trtnation.com/faqs-2026/

3

2

2

https://trtplug.com/compare-trt-clinics/

3

2

2

https://help.honehealth.com/hc/en-us/articles/40162110574103-Hone-Plus-Membership-Men-s-Hormone-Optimization-with-Labs

2

2

2

https://marekhealth.com/testosterone

1

1

2

https://muscleandfitness.com/supplements/best-online-trt-clinics/

6

4

1

https://rxpepsdirect.com/learn/ways2well-alternatives

5

4

1

These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.

Several cited pages relate to Defy Medical in the captured answers, and a few of them are linked to conflicting claims. That link is a reason to look, not a finding of fault. A page connected to a disputed claim may not be its cause, and the same answer can touch more than one page.

The sensible approach is a prioritized source review. Pages that appear repeatedly and connect to the high-priority conflict come first, with their current contents checked against primary sources before any request is made. Publisher control and publisher error are both assumptions we should avoid.

Where a genuine gap is confirmed, we would propose an evidence-backed request rather than a demand. Where the page turns out to be accurate, the outcome is a documented no-change decision, which is just as useful to record.

Step 4. Optimize priority company pages

Questions This Section Answers

  • Which observed Defy Medical website pages should receive review briefs?

Company website page

Citation appearances in all captured answers

Benchmark answers citing the page

Recommending answers citing the page

https://defymedical.com/services/trt/

8

8

8

https://defymedical.com/services/trimix-injections/

4

0

0

https://defymedical.com/blog/the-power-of-trimix-injections/

3

0

0

https://defymedical.com/faq/how-much-does-trt-cost-with-defy-medical/

2

2

1

https://defymedical.com/blog/applying-topical-hormone-cream-bi-est-estrogen/

1

0

0

https://defymedical.com/blog/does-testosterone-make-you-gain-weight/

1

1

0

The company's website was cited 19 times across 6 distinct page addresses; the table shows 6 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.

The company's own site is already being cited, and the testosterone service page accounts for the largest share of those citations. That page is the natural anchor for any consistency work, because it is the one the answers most often draw on.

The other selected pages show a different pattern: several are cited without appearing in recommending answers. That does not prove they are weak, but it does make them worth reviewing for clarity, completeness and alignment with approved facts.

We would propose page briefs built from approved facts and real audience questions, starting with the anchor page and then the supporting treatment and cost pages. Each brief would note what the page should say, not assume what it currently says.

Step 5. Publish around buyer questions

Questions This Section Answers

  • Which observed buyer questions support content briefs for Defy Medical?

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

What is the best online TRT clinic?

5

5

5

Which TRT company is best?

5

4

4

What is the best TRT company?

4

3

3

What is the best company to get TRT from?

4

3

3

What is the best online TRT company?

4

3

3

What is the best online TRT?

4

3

3

What is the most reputable TRT company?

3

3

3

Where is the best place to get TRT online?

4

3

3

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

The recorded questions cluster tightly around a single theme: which clinic or company is best. Defy Medical appears in most of these answers and is recommended in most of those appearances, which suggests the brand is already part of the comparison conversation rather than absent from it.

These are answer observations, not search volume or verified demand. They show what people asked in this research, not how many people are asking it elsewhere. That limit matters when deciding how much content to commission.

We would propose buyer-question briefs that check existing coverage first. Where a page already addresses the question, the brief is about sharpening it; where nothing covers it, a new page can be considered. Either way, the content should answer the comparison honestly rather than repeat the brand's own claims.

Our 90-day action plan

Questions This Section Answers

  • How should the agency sequence the proposed Defy Medical work and judge completion?

Period

Deliverable

Completion criterion

Days 1–30

Baseline scorecard, scoped fact-review register and page/source shortlist

Each record has an owner, evidence requirement and review status

Days 31–60

Approved page briefs and justified publisher requests

Separate confirmed edits, no-change decisions, requests and responses

Days 61–90

Buyer-content briefs and a fresh scorecard

Record work completed separately from measured answer outcomes and comparability limits

The first phase establishes the working base: a baseline scorecard, a scoped fact-review register and a shortlist of pages and sources. Each record needs an owner, an evidence requirement and a review status, so nothing sits in limbo.

The middle phase turns confirmed facts into page briefs and justified publisher requests. Confirmed edits, no-change decisions, requests and responses are recorded separately, because a request sent is not a correction made.

The final phase produces buyer-content briefs and a fresh scorecard. Completed work is reported apart from measured answer outcomes, and the comparability limits stay visible. Nothing in this plan promises a visibility gain; it promises a cleaner, better-evidenced position from which future editions can be judged.

Methodology

Questions This Section Answers

  • How are Defy Medical answer metrics and citation populations defined?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 363 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 5316 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

Reporting month

Answers included

AI services covered

Services

Nov 2026

363

6

ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity

Earlier editions (July 2026, August 2026, September 2026 and October 2026) used a narrower set of questions. This edition includes all captured answers screened as relevant and establishes a broader baseline. Earlier figures remain in the archive; they are not used to claim a change in performance.

Future editions using the same screening scope can be compared against this baseline.

The visibility figures rest on answers that met the benchmark's inclusion rules, and the exact collection dates for the original answers have not been verified. A company counts as recommended only when an answer endorses it with positive wording; shortlist and first-place counts sit inside those recommendations rather than adding to them.

Answers can mention several companies, so company counts cannot be summed into a number of distinct answers. Sentiment describes answer wording, not customer satisfaction. The citation analysis covers a wider set of captured answers than the benchmark, and cited pages still need independent checking.

Earlier editions used a narrower question set, so this edition is a broader baseline rather than a performance trend. Future editions using the same scope can be compared against it.

Our first three priorities

First, verify the high-priority membership conflict and the pricing descriptions against current primary sources. Until that is done, neither version should be treated as correct, and no correction request should go out. The medium-priority pricing items can follow once the entity and date questions are settled.

Second, strengthen the testosterone service page, which is the site's most-cited asset in these answers, and review the supporting treatment and cost pages for alignment with approved facts. Page briefs should be written from confirmed information and real audience questions, not from assumptions about what a page currently says.

Third, build buyer-question content around the best-clinic comparisons, checking existing coverage before commissioning anything new. A fresh scorecard at the end of the cycle will show what was completed, while keeping measured outcomes and comparability limits clearly separate from the work delivered.

This report supports CiteWorks Studio's examination of how AI search is recommending TRT Clinics. For more detail, you can also read TRT Clinics: AI Visibility Discovery Index.

/ Learn More

Understanding AI search visibility.

AI search experiences create answers by pulling information from many places online and summarizing it into a single response.

What Is AI Citation Intelligence?
AI citation intelligence is the process of measuring where AI platforms source their information and how frequently a brand is mentioned or referenced in AI-generated responses. Because LLMs synthesize across multiple sources, the sites and brands that appear repeatedly tend to influence how a topic or company is framed. This practice focuses on identifying which sources shape AI outputs and tracking brand visibility across different AI systems.
What Is Citation Architecture?
Citation architecture describes the set of sources that consistently inform how AI systems talk about a brand, product, or topic. LLMs draw from websites, articles, forums, and public discussion, and the sources they rely on most often become the backbone of their answers. Building strong citation architecture means ensuring that accurate, credible, high authority sources are the ones most likely to shape the way AI tools summarize and recommend a brand.
What Is Generative Engine Optimization?
Generative engine optimization (GEO) is the practice of improving the chances that AI systems use and cite your brand or content when generating answers. While traditional SEO is centered on ranking pages in search results, GEO focuses on how LLMs retrieve, interpret, and combine information when responding to a question. The objective is to strengthen the content and sources AI systems rely on, so your brand is treated as a trusted reference in AI responses.
What Is AI Share of Voice?
AI share of voice tracks how often a brand appears in AI-generated answers compared with competitors in the same category. It reflects visibility across AI platforms such as ChatGPT, Gemini, Claude, and Perplexity. Monitoring AI share of voice helps organizations see whether AI systems consistently include and recommend their brand for key queries or whether competitor brands are showing up more often.

About The Author

Mark Huntley

Mark Huntley

Founder and CEO

Mark Huntley, J.D. is founder of CiteWorks Studio, a strategic advisory focused on visibility, authority, and recommendation presence in AI-shaped search environments. His work centers on embedding-level GEO, vector optimization, and cosine gap engineering — helping brands align their digital presence with the retrieval systems that increasingly shape discovery, interpretation, and choice.

VIEW ALL CASE STUDIESREQUEST AN AI VISIBILITY AUDIT